Study: 150 Patients with Vitiligo

Evaluation of narrow-band UVB phototherapy in 150 patients with vitiligo

Link to entire article << Click Here >>

Y Hari Kishan Kumar, G Raghu Rama Rao, K.V.T Gopal, G Shanti, K Veerabhadra Rao
Department of Dermatology, King George Hospital/Andhra Medical College, Visakhapatnam, Andhra Pradesh, India and Department of Dermatology, Surya Skin Care and Research Centre, Visakhapatnam, Andhra Pradesh, India

Correspondence Address:
G Raghu Rama Rao
Department of Dermatology, Andhra Medical College, Surya Skin Care and Research Centre, Visakhapatnam, Andhra Pradesh India

DOI: 10.4103/0378-6323.48662

Abstract   

Background: Very few studies have been performed to evaluate the efficacy and safety of narrow-band ultraviolet B (NBUVB) therapy in Indian patients with vitiligo and are of small sample size.

Aims: The purpose of this study is to know the efficacy and safety of NBUVB in 150 vitiligo patients of various age groups.

Methods: One hundred fifty patients (69 males, 81 females), aged 3-70 years, with vitiligo were treated twice weekly with NBUVB. The starting dose was 250 mJ/cm 2 in adults and 150 mJ/cm 2 in children, with 20% dose increments at each subsequent visit given for a maximum period of 1 year and were followed-up for 6 months for stability of repigmentation. Statistical methods were employed to establish the relation between the response and the number of exposures, duration of treatment, cumulative dose and the compliance.

Results: Analysis of our study showed that a majority of our cases, about 73, achieved 25-75% repigmentation, with an average of 51 ± 19 exposures, 51 had <25% repigmentation, with an average of 19 ± 11 exposures and 26 had >75% repigmentation, with an average of 74 ± 24 exposures. Good response to therapy was directly associated with good compliance, more number of exposures and increasing cumulative dose, which was statistically significant (P < 0.01). Adverse effects were minimal. Only three patients developed depigmentation of repigmented sites during follow-up.

Conclusion: Our study proves that NBUVB therapy is an effective and safe tool in the management of vitiligo, with good stability of repigmentation and cosmetic appearance.

Full article: <<Click Here>>

Share and Enjoy:
  • Facebook
  • Digg
  • Twitter
  • RSS
  • StumbleUpon
  • del.icio.us
  • Google Bookmarks
  • LinkedIn
  • FriendFeed
This entry was posted in Medical Articles, Skin Diseases and tagged , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

*


*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>